Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826) has released an update.
Shanghai Haohai Biological Technology Co., Ltd. has released its unaudited third-quarter financial report for 2024 and announced strategic amendments to enhance corporate governance. The company has restructured its committees by shifting ESG responsibilities to a newly renamed Strategy and Sustainable Development Committee, aiming to bolster its sustainability efforts.
For further insights into HK:6826 stock, check out TipRanks’ Stock Analysis page.